Effect of Antifibrotic Use on Mortality in Patients with Idiopathic Pulmonary Fibrosis

Observational studies report a significant protective effect of antifibrotics on mortality among patients with idiopathic pulmonary fibrosis (IPF). Many of these studies, however, were subject to immortal time bias because of the mishandling of delayed antifibrotic initiation.